
Ketoconazole
Oral ketoconazole is a last-resort antifungal for serious body-wide fungal infections. Old randomized dose-comparison trials found success rates of 79% to 100% in blastomycosis and about 85% in histoplasmosis after 6 months or more, but only 23% to 32% in progressive coccidioidomycosis. Its boxed warning covers fatal liver injury, QT prolongation and dangerous drug interactions. Calcium and other antacids, St. John's wort and yeast-based probiotics are the main supplement issues.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis or paracoccidioidomycosis who failed or cannot tolerate other antifungal treatment, treated and monitored by a prescriber
Common dosing range
Set by your prescriber. The label starting dose is 200 mg once daily, which may be raised to 400 mg once daily if the response is not enough; the usual course for a systemic infection is 6 months
When to expect effects
Slow. The label says the usual duration for a systemic infection is 6 months, continued until the infection has subsided
Watch out for
Serious liver injury, including deaths and liver transplants, even in people without risk factors; weekly liver blood tests are part of the label. It is contraindicated with many drugs (for example simvastatin, lovastatin, alprazolam, triazolam, dofetilide, quinidine, methadone). Acid reducers lower absorption, and the label advises against alcohol
What is it
Ketoconazole is an azole antifungal. As a 200 mg tablet taken by mouth it is a prescription medicine that the FDA now limits to serious fungal infections spread through the body (blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis and paracoccidioidomycosis) in people who failed or cannot take other antifungals. Because of serious liver injury, heart rhythm problems and drug interactions, the tablet label says it should not be used for nail fungus, ringworm-type skin infections (cutaneous dermatophyte infections) or Candida (yeast) infections, and only when other effective treatment is not available or tolerated. Ketoconazole is also sold as creams and shampoos, including the Nizoral shampoo brand, for skin and scalp conditions. Those topical products are a different situation: the interactions on this page are about the tablets taken by mouth.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
blastomycosis and histoplasmosis Limited Evidence | Success in 79% to 100% for blastomycosis and about 85% for histoplasmosis after 6 months or more | Immunocompetent adults with non-life-threatening, non-meningeal blastomycosis or histoplasmosis who cannot use other antifungals | Courses of 6 months or more |
progressive coccidioidomycosis (valley fever) Limited Evidence | Small; about 1 in 4 to 1 in 3 patients had a successful course | Adults with non-meningeal progressive coccidioidomycosis who cannot use other antifungals | Courses lasting months |
high cortisol in Cushing's disease (off-label in the US) Mixed Evidence | About half reached normal urinary cortisol in an uncontrolled review | Adults with Cushing's disease managed by an endocrinologist, outside the US labeled uses | Not defined in this study |
blastomycosis and histoplasmosis
- Effect
- Success in 79% to 100% for blastomycosis and about 85% for histoplasmosis after 6 months or more
- Best fit
- Immunocompetent adults with non-life-threatening, non-meningeal blastomycosis or histoplasmosis who cannot use other antifungals
- Time
- Courses of 6 months or more
progressive coccidioidomycosis (valley fever)
- Effect
- Small; about 1 in 4 to 1 in 3 patients had a successful course
- Best fit
- Adults with non-meningeal progressive coccidioidomycosis who cannot use other antifungals
- Time
- Courses lasting months
high cortisol in Cushing's disease (off-label in the US)
- Effect
- About half reached normal urinary cortisol in an uncontrolled review
- Best fit
- Adults with Cushing's disease managed by an endocrinologist, outside the US labeled uses
- Time
- Not defined in this study
Evidence for 3 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
blastomycosis and histoplasmosis
Disease adjunctIn a multicenter trial from the US Mycoses Study Group, 134 patients (80 with blastomycosis and 54 with histoplasmosis) were randomly assigned to ketoconazole 400 mg or 800 mg a day. Among 65 people with blastomycosis treated for 6 months or more, success was 100% with 800 mg versus 79% with 400 mg. Among people with histoplasmosis treated for 6 months or more, overall success was 85%. Side effects occurred in 60% of all patients and were more common at the higher dose. There was no placebo or comparison antifungal, the trial studied immunocompetent people with non-life-threatening, non-meningeal disease, and today the label reserves ketoconazole for people who cannot use other antifungals.
Bottom line: An older dose-comparison trial found ketoconazole usually controlled blastomycosis and histoplasmosis over 6 months, with frequent side effects.
progressive coccidioidomycosis (valley fever)
Disease adjunct112 patients with progressive lung, bone or soft tissue coccidioidomycosis were randomly assigned to ketoconazole 400 mg or 800 mg a day. Success was 23.2% with 400 mg and 32.1% with 800 mg, a difference that was not statistically significant. Only 6 of 23 people who failed and moved to 1,200 or 1,600 mg a day improved, and relapses were more frequent in people who needed doses above 400 mg. The authors concluded that higher doses offer little or no benefit for most people with non-meningeal coccidioidomycosis. There was no placebo group.
Bottom line: Ketoconazole helped only a minority of people with progressive coccidioidomycosis, and higher doses did not do clearly better.
high cortisol in Cushing's disease (off-label in the US)
Biomarker supportOff-label use: the US label says ketoconazole is not approved for Cushing's syndrome and its safety and effectiveness have not been established there. A French retrospective study reviewed 200 patients with Cushing's disease treated with ketoconazole alone (median final dose 600 mg a day). At last follow-up, 49.3% had normal urinary free cortisol, 25.6% had at least a 50% fall, and 25.4% had no change. 20.5% stopped because of poor tolerance; liver enzymes rose to less than 5 times normal in 13.5% and above 5 times normal in 2.5%. The study had no control group and measured a laboratory marker, not long-term outcomes.
Bottom line: In an uncontrolled review, ketoconazole normalized urinary cortisol in about half of people with Cushing's disease, but this is not an approved US use.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose. Take it with a meal, keep antacids apart as the label states, avoid alcohol, and keep every liver test appointment.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: serious liver injury (hepatotoxicity), including cases that were fatal or needed a liver transplant, sometimes in people with no obvious liver risk factors, and with both high doses for short courses and low doses for long courses. The label requires baseline liver tests and weekly ALT checks during treatment.
Boxed warning: QT prolongation and life-threatening heart rhythm problems (torsades de pointes) when ketoconazole raises the levels of drugs such as dofetilide, quinidine, pimozide, lurasidone, cisapride, methadone, disopyramide, dronedarone and ranolazine; these combinations are contraindicated. At 200 mg twice daily, ketoconazole itself raised the QTc by about 6 to 12 msec at peak levels.
Boxed warning: because of these serious adverse reactions, the tablets are not indicated for nail fungus, ringworm-type skin infections (cutaneous dermatophyte infections) or Candida infections and should be used only when other effective antifungal therapy is not available or tolerated.
Low adrenal function (adrenal insufficiency): ketoconazole lowers adrenal steroid output at doses of 400 mg and higher.
Lower testosterone, impaired at 800 mg a day, which can cause breast enlargement, impotence and low sperm counts; levels return to baseline after stopping.
Serious allergic reactions, including anaphylaxis after the first dose.
Who should avoid it
- People with acute or chronic liver disease: contraindicated
- People taking a contraindicated medicine, including dofetilide, quinidine, pimozide, cisapride, methadone, disopyramide, dronedarone, ranolazine, lurasidone, ergot alkaloids, irinotecan, oral midazolam, alprazolam, triazolam, felodipine, nisoldipine, tolvaptan, eplerenone, lovastatin, simvastatin or colchicine
- People with nail fungus, ringworm-type skin infections (cutaneous dermatophyte infections) or Candida infections: the label says the tablets are not indicated for these
- People with a past allergic reaction to ketoconazole
- Breastfeeding mothers: the label says mothers taking ketoconazole tablets should not breastfeed
Pregnancy & breastfeeding
Pregnancy: the label says there are no adequate studies in pregnant women and that ketoconazole tablets should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus; it caused finger and toe defects in rats at about 2 times the maximum recommended human dose, which the label says may be related to toxicity in the mother. Breastfeeding: the label says ketoconazole passes into breast milk and mothers taking the tablets should not breastfeed. Talk with your prescriber before starting if you are pregnant, planning a pregnancy or breastfeeding.
Interactions
The boxed warning says ketoconazole raises the levels of these drugs and can cause life-threatening heart rhythm problems, so the combinations are contraindicated. Make sure every prescriber knows you take ketoconazole.
The label contraindicates these statins with ketoconazole because higher statin levels raise the risk of muscle breakdown (rhabdomyolysis). Your prescriber will plan around your cholesterol medicine during the course.
St. John's wort strongly speeds up CYP3A4, the enzyme that clears ketoconazole. The ketoconazole label says potent CYP3A4 inducers may lower its levels enough to reduce effectiveness and should be avoided from 2 weeks before and during treatment. No study has measured ketoconazole levels with St. John's wort, but in a study that also used ketoconazole, St. John's wort alone raised CYP3A activity 6.6-fold, and in 16 healthy men, 15 days of it cut levels of the related antifungal voriconazole by 59%. Tell your prescriber if you take St. John's wort or took it in the past 2 weeks.
S. boulardii is a live yeast, so a systemic antifungal would be expected to cancel its effect, although no study has measured this with ketoconazole. The bigger issue is safety: in Finnish hospitals, at least 20 of 46 people with Saccharomyces bloodstream infection were taking an S. boulardii probiotic (odds ratio 14), and an intensive care outbreak was traced to it. Tell your prescriber if you use it; they can advise whether to pause it.
These lower stomach acid, which ketoconazole needs to be absorbed: after omeprazole, absorption fell to 17% of normal, and taking ketoconazole with non-diet cola brought it back to 65%. The label says to use them with caution, take ketoconazole with an acidic drink, and have the antifungal effect monitored.
Red yeast rice contains monacolin K, the same molecule as lovastatin, and the ketoconazole tablet label contraindicates lovastatin because higher statin levels raise the risk of muscle breakdown (rhabdomyolysis). Red yeast rice itself has not been studied with ketoconazole, and 12 tested products contained 0.10 to 10.09 mg of monacolin K per capsule. Do not use it during a course of ketoconazole tablets unless your prescriber has reviewed it; creams and shampoos are not the concern.
Ketoconazole tablets need stomach acid to dissolve, and the label says acid-neutralizing antacids impair absorption and should be taken at least 1 hour before or 2 hours after ketoconazole. Calcium carbonate antacids work this way; the effect of a plain calcium supplement taken for bone health is less certain. Ask your pharmacist how to time any calcium product.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (3)
+ red yeast rice
highOral ketoconazole tablets strongly block CYP3A4, the enzyme that breaks down lovastatin. Red yeast rice's monacolin K is the same molecule as lovastatin, and both the ketoconazole tablet label and the lovastatin label contraindicate lovastatin with ketoconazole because higher statin levels raise the risk of muscle injury, including rhabdomyolysis. Red yeast rice itself has not been studied with ketoconazole, and products vary widely in how much monacolin K they contain. Ketoconazole creams and shampoos are not covered by the tablet label's warnings.
+ st. john's wort
highSt. John's wort strongly speeds up CYP3A4, the enzyme that clears oral ketoconazole. The ketoconazole label says potent CYP3A4 inducers may lower ketoconazole enough to reduce its effect, are not recommended, and should be avoided from 2 weeks before and during treatment; St. John's wort is not named there. No study has measured ketoconazole levels with St. John's wort, but in a study that also used ketoconazole, St. John's wort alone raised CYP3A activity (midazolam clearance) 6.6-fold, and 15 days of it cut levels of the related antifungal voriconazole by 59 percent. Topical ketoconazole is not a practical concern.
+ calcium
moderateOral ketoconazole tablets need stomach acid to dissolve and be absorbed. The ketoconazole label says acid-neutralizing antacids impair its absorption and should be taken at least 1 hour before or 2 hours after it. Calcium carbonate, the form in Tums and many calcium supplements, neutralizes stomach acid, so taking it at the same time can lower ketoconazole levels and its antifungal effect. Topical ketoconazole is not affected.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take calcium or an antacid with ketoconazole?⌄
Not at the same time. Ketoconazole needs stomach acid to be absorbed, and the label says acid-neutralizing antacids should be taken at least 1 hour before or 2 hours after it. Calcium carbonate antacids work this way. Ask your pharmacist how to time any calcium product.
Is St. John's wort safe with ketoconazole?⌄
It may make ketoconazole less effective. St. John's wort speeds up the enzyme that clears ketoconazole; it cut levels of a related antifungal by 59% in a small study. The label says to avoid strong enzyme inducers from 2 weeks before treatment. Tell your prescriber if you take it.
Can I keep taking probiotics during ketoconazole treatment?⌄
Bacterial probiotics are not expected to be affected, because ketoconazole targets a fungal membrane component that bacteria lack. Yeast probiotics (Saccharomyces boulardii) are different: an antifungal would be expected to act on them, and they have caused bloodstream infections in vulnerable people. Ask your prescriber about your product.
Can I drink alcohol while taking ketoconazole?⌄
The label advises against alcohol during treatment because of the risk of liver injury, and rare flushing and nausea reactions to alcohol have been reported.
Is the shampoo the same as the tablets?⌄
No. Ketoconazole shampoo and cream act on the skin and scalp. The boxed warning about liver injury, heart rhythm and drug interactions is on the tablet label, and the interactions on this page concern the tablets.
References by claim
blastomycosis and histoplasmosis
PMID 2865921 · PubMed (1985) link
progressive coccidioidomycosis (valley fever)
Galgiani et al., 1988 · PubMed (1988) link
high cortisol in Cushing's disease (off-label in the US)
Castinetti et al., 2014 · PubMed (2014) link
Safety
Ketoconazole tablets USP 200 mg prescribing information and Medication Guide · DailyMed (FDA label) link
Interaction: St. John's wort
Interaction: Saccharomyces boulardii (yeast probiotic)
Track Ketoconazole with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
